Ryan Specialty Group (RYAN) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
8 Jul, 2026Executive summary
Total revenue for Q1 2025 increased 25% year-over-year to $690.2 million, driven by 12.9% organic growth and significant M&A contributions, including Velocity Risk Underwriters and USQ Risk.
Adjusted EBITDAC/EBITDA rose 27.5% to $200.5 million, with margin expanding to 29.1%.
Adjusted EPS increased 11.4% to $0.39, while adjusted net income grew 13% to $107.8 million.
Net income turned negative, with a GAAP net loss of $4.4 million to $27.6 million, primarily due to a $48.1 million non-recurring, non-cash tax expense from the Velocity acquisition reorganization.
Strong performance attributed to new client wins, expanded relationships, and E&S market growth.
Financial highlights
Net commissions and fees rose 25.7% to $676.1 million; fiduciary investment income was $14.0 million.
Operating income increased 38% to $100.2 million year-over-year.
Adjusted EBITDAC/EBITDA margin improved to 29.1% from 28.5% year-over-year.
Adjusted net income margin was 15.6%, down from 17.3% year-over-year.
Net income margin dropped to (0.6)% from 7.4% year-over-year, impacted by non-cash tax expense.
Outlook and guidance
Full-year 2025 guidance maintained: organic revenue growth of 11–13% and adjusted EBITDA/EBITDAC margin of 32.5–33.5%.
Management expects continued growth through strategic acquisitions, broker relationship expansion, and delegated authority business.
Investments in technology and talent are planned to support long-term growth and innovation.
Expect continued modest growth in property and strong growth in casualty for the remainder of the year.
M&A remains a top capital allocation priority, with a robust pipeline of deals.
Latest events from Ryan Specialty Group
- Q3 revenue up 20.5%, net income up 82.4%, and adjusted EBITDAC up 29.4% year-over-year.RYAN
Q3 20248 Jul 2026 - Revenue up 18.8% and net income up 40.8%, with margin and guidance both raised.RYAN
Q2 20248 Jul 2026 - Scale, innovation, and disciplined growth drive resilience and leadership in specialty insurance.RYAN
46th Annual William Blair Growth Stock Conference4 Jun 2026 - Revenue up 15.2% to $795.2M, organic growth 11.8%, net income $40.6M, margin pressure ahead.RYAN
Q1 20264 May 2026 - Record revenue, expanded shareholder rights, and a focus on performance-based leadership mark 2025.RYAN
Proxy Filing17 Mar 2026 - Shareholders will vote on director elections, auditor ratification, and executive pay approval.RYAN
Proxy Filing17 Mar 2026 - 2025 revenue up 21.3% to $3.1B, with 10.1% organic growth and $300M buyback authorized.RYAN
Q4 202527 Feb 2026 - Q2 revenue up 23% to $855.2M, net income up 5.6%, guidance lowered amid property headwinds.RYAN
Q2 202512 Feb 2026 - Q3 revenue up 25% and net income up 118.6%, with strong organic growth and margin pressures from investments.RYAN
Q3 202512 Feb 2026